2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial.

M Bachner; Y Loriot; M Gross-Goupil; P A Zucali; A Horwich; J-R Germa-Lluch; C Kollmannsberger; F Stoiber; A Fléchon; Karin Oechsle; S Gillessen; J Oldenburg; G Cohn-Cedermark; G Daugaard; F Morelli; A Sella; S Harland; M Kerst; J Gampe; C Dittrich; K Fizazi; M De Santis

doi:10.1093/annonc/mdr052

2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial.

M Bachner
Y Loriot
M Gross-Goupil
P A Zucali
A Horwich
J-R Germa-Lluch
C Kollmannsberger
F Stoiber
A Fléchon
Karin Oechsle
S Gillessen
J Oldenburg
G Cohn-Cedermark
G Daugaard
F Morelli
A Sella
S Harland
M Kerst
J Gampe
C Dittrich
K Fizazi
M De Santis

Related Research units

II. Department of Medicine

Abstract

2-¹?fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) has been recommended in international guidelines in the evaluation of postchemotherapy seminoma residuals. Our trial was designed to validate these recommendations in a larger group of patients.

Bibliographical data

Original language	English
Article number	1
ISSN	0923-7534
DOIs	https://doi.org/10.1093/annonc/mdr052
Publication status	Published - 01.2012